MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Medical Imaging (Molecular, Functional-PET, Gamma & Nuclear Medicine) Company
Indi Molecular
Attachments
www.indimolecular
Parents
*Architects: Medical Imaging (Molecular, Functional-PET, Gamma & Nuclear Medicine) Company
*Portfolio Companies: Interwest
2013: Deals Update October 2013_lifescienceintelligence
Venture Capital: Angel, Seed & Incubator Series
Children
Chemotherapy can similarly be specifically delivered to diseased cells by the protein catalyzed capture technology.
For radiotherapy this dual role is accomplished by choice of the complexed radionuclide sharing the same chelation chemistry.
Founded 2013
Indi Molecular is developing a synthetic protein chemistry platform to transform targeted therapeutic and molecular imaging.
PCCs are poised to play a central role in therapy given their ability to be deployed as both a precision in vivo PET diagnostic and as a targeted therapeutic.
Protein catalyzed capture (PCC) agents are small synthetic molecule replacements for antibody-based therapeutics.